Ubiquigent and the University of York Awarded a grant to explore the potential of deubiquitylase (DUB) enzyme inhibitors to address neglected tropical diseases
January 14, 2021
January 14, 2021
January 11, 2021
December 16, 2020
December 8, 2020
November 30, 2020
November 17, 2020
November 10, 2020
November 5, 2020
October 15, 2020
January 8, 2025
Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicin...
December 16, 2024
BetaGlue® Therapeutics S.p.A. (“BetaGlue”) an Italian clinical-stage oncology company developing an innovative radiotherapy platform for the targeted ...
December 11, 2024
The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225